LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 33.32 | 84.90 | 1434 | 2722 | 0.5267 | 0.7595 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.03 | 84.90 | 37 | 2991 | 0.0124 | -0.1492 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.03 | 84.90 | 1183 | 2991 | 0.3955 | 0.6697 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.03 | 84.90 | 141 | 2991 | 0.0471 | 0.1038 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 35.03 | 84.90 | 1483 | 2991 | 0.4958 | 0.7448 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.73 | 84.90 | 55 | 3254 | 0.0169 | -0.0792 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.73 | 84.90 | 1242 | 3254 | 0.3817 | 0.6654 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.73 | 84.90 | 163 | 3254 | 0.0501 | 0.1320 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 36.73 | 84.90 | 1532 | 3254 | 0.4708 | 0.7331 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.43 | 84.90 | 58 | 3459 | 0.0168 | -0.0688 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.43 | 84.90 | 1285 | 3459 | 0.3714 | 0.6619 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.43 | 84.90 | 197 | 3459 | 0.0569 | 0.1704 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.43 | 84.90 | 1608 | 3459 | 0.4648 | 0.7331 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.14 | 84.90 | 68 | 3682 | 0.0185 | -0.0400 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.14 | 84.90 | 1343 | 3682 | 0.3647 | 0.6615 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.14 | 84.90 | 209 | 3682 | 0.0568 | 0.1802 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.14 | 84.90 | 1652 | 3682 | 0.4487 | 0.7260 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.84 | 84.90 | 65 | 4003 | 0.0162 | -0.0469 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.84 | 84.90 | 1398 | 4003 | 0.3492 | 0.6552 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.84 | 84.90 | 234 | 4003 | 0.0585 | 0.2001 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 41.84 | 84.90 | 1703 | 4003 | 0.4254 | 0.7150 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 43.55 | 84.90 | 75 | 4287 | 0.0175 | -0.0217 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 43.55 | 84.90 | 1471 | 4287 | 0.3431 | 0.6555 | MN20160318_Q02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 43.55 | 84.90 | 259 | 4287 | 0.0604 | 0.2179 | MN20160318_Q02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 43.55 | 84.90 | 1780 | 4287 | 0.4151 | 0.7122 | MN20160318_Q02 | L16 |